Sylvie Beaudenon‐Huibregtse

Author

Asuragen (United States)

Also Known As

Sylvie Beaudenon-Huibregtse, Sylvie Beaudenon‐Huibregtse

Publications

634

Citations

H-Index

Concepts

All Affiliations

Asuragen (United States)Michigan Medicine University of Michigan

About

Sylvie Beaudenon‐Huibregtse is an author at Asuragen (United States) specializing in genetics, medicine, and thyroid disorders.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	105
2	Pathology	2	2	105
3	Epigenetics	1	1	55
4	Functional Genomics	1	1	55
5	Gene Expression	1	1	55

Sylvie Beaudenon‐Huibregtse

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology Emmanuel Labourier, Alexander L. Shifrin, Anne E. Busseniers, The Journal of Clinical Endocrinology & Metabolism	2015	273
Centralized Molecular Testing for Oncogenic Gene Mutations Complements the Local Cytopathologic Diagnosis of Thyroid Nodules Sylvie Beaudenon‐Huibregtse, Erik K. Alexander, Richard Guttler, Thyroid	2014	128
Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions Sogol Mostoufi‐Moab, Emmanuel Labourier, Lisa Sullivan, Thyroid	2017	78
Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations Dennis Wylie, Sylvie Beaudenon‐Huibregtse, Brian C. Haynes, The Journal of Pathology Clinical Research GeneticsPathologyGenomicsEpigeneticsThyroid Lesions	2016	55
Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens Thomas J. Giordano, Sylvie Beaudenon‐Huibregtse, Rupali Shinde, Human Pathology Oncogenic Gene MutationsGeneticsPostsurgical SpecimensThyroid DiseasePathology	2014	50
SARS-CoV-2 viral load is associated with risk of transmission to household and community contacts Darlene Bhavnani, Emily James, Kaitlyn E. Johnson, BMC Infectious Diseases	2022	37
A Multiplex Technology Platform for the Rapid Analysis of Clinically Actionable Genetic Alterations and Validation for BRAF p.V600E Detection in 1549 Cytologic and Histologic Specimens David L. Smith, Aude Lamy, Sylvie Beaudenon‐Huibregtse, Archives of Pathology & Laboratory Medicine	2013	10

Page 1